Advertisement

Prostate MR: pitfalls and benign lesions

  • 145 Accesses

Abstract

Multiparametric MRI (mpMRI) of the prostate has evolved to be an integral component for the diagnosis, risk stratification, staging, and targeting of prostate cancer. However, anatomic and histologic mimics of prostate cancer on mpMRI exist. Anatomic feature that mimic prostate cancer on mpMRI include anterior fibromuscular stroma, normal central zone, periprostatic venous plexus, and thickened surgical capsule (transition zone pseudocapsule). Benign conditions such as post-biopsy hemorrhage, prostatitis or inflammation, focal prostate atrophy, benign prostatic hyperplasia nodules, and prostatic calcifications can also mimic prostate cancer on mpMRI. Technical challenges and other pitfalls such as image distortion, motion artifacts, and endorectal coil placements can also limit the efficacy of mpMRI. Knowledge of prostate anatomy, location of the lesion and its imaging features on different sequences, and being familiar with the common pitfalls are critical for the radiologists who interpret mpMRI. Therefore, this article reviews the pitfalls (anatomic structures and technical challenges) and benign lesions or abnormalities that may mimic prostate cancer on mpMRI and how to interpret them.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

References

  1. 1.

    Borofsky S, George AK, Gaur S, et al. What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate. Radiology. 2018; 286(1):186-95.

  2. 2.

    Fütterer JJ, Briganti A, De Visschere P, et al. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. European Urology. 2015; 68(6):1045-53.

  3. 3.

    Niaf E, Lartizien C, Bratan F, et al. Prostate Focal Peripheral Zone Lesions: Characterization at Multiparametric MR Imaging—Influence of a Computer-aided Diagnosis System. Radiology. 2014; 271(3):761-9.

  4. 4.

    Kiyoshima K, Yokomizo A, Yoshida T, et al. Anatomical Features of Periprostatic Tissue and its Surroundings: a Histological Analysis of 79 Radical Retropubic Prostatectomy Specimens. Japanese Journal of Clinical Oncology. 2004; 34(8):463-8.

  5. 5.

    Kiyoshima K, Yokomizo A, Yoshida T, et al. Anatomical features of periprostatic tissue and its surroundings: a histological analysis of 79 radical retropubic prostatectomy specimens. Jpn J Clin Oncol. 2004; 34(8):463-8.

  6. 6.

    Ward E, Baad M, Peng Y, et al. Multi-parametric MR imaging of the anterior fibromuscular stroma and its differentiation from prostate cancer. Abdom Radiol (NY). 2017; 42(3):926-34.

  7. 7.

    Koppie TM, Bianco FJ, Jr., Kuroiwa K, et al. The clinical features of anterior prostate cancers. BJU Int. 2006; 98(6):1167-71.

  8. 8.

    Bouye S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate. 2009; 69(1):105-13.

  9. 9.

    Panebianco V, Giganti F, Kitzing YX, et al. An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines. Insights into Imaging. 2018; 9(1):87-101.

  10. 10.

    McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol. 1968; 49(3):347-57.

  11. 11.

    Vargas HA, Akin O, Franiel T, et al. Normal Central Zone of the Prostate and Central Zone Involvement by Prostate Cancer: Clinical and MR Imaging Implications. Radiology 2012; 262(3):894-902.

  12. 12.

    Gupta RT, Kauffman CR, Garcia-Reyes K, et al. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer. AJR Am J Roentgenol. 2015; 205(2):331-6.

  13. 13.

    Hansford BG, Karademir I, Peng Y, et al. Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate. Acad Radiol. 2014; 21(5):569-77.

  14. 14.

    Rosenkrantz AB, Taneja SS. Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol. 2014; 202(1):109-20.

  15. 15.

    Cohen RJ, Shannon BA, Phillips M, Moorin RE, Wheeler TM, Garrett KL. Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. J Urol. 2008; 179(5):1762-7; discussion 7.

  16. 16.

    Cristini C, Di Pierro GB, Leonardo C, De Nunzio C, Franco G. Safe digital isolation of the santorini plexus during radical retropubic prostatectomy. BMC Urol. 2013; 13:13.

  17. 17.

    Allen KS, Kressel HY, Arger PH, Pollack HM. Age-related changes of the prostate: evaluation by MR imaging. AJR Am J Roentgenol. 1989; 152(1):77-81.

  18. 18.

    Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ. The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol. 1989; 13(1):21-7.

  19. 19.

    Poon PY, Bronskill MJ, Poon CS, McCallum RW, Bruce AW, Henkelman RM. Identification of the Periprostatic Venous Plexus by MR Imaging. Journal of computer assisted tomography. 1991; 15(2):265-8.

  20. 20.

    Bhavsar A, Verma S. Anatomic imaging of the prostate. Biomed Res Int. 2014; 2014:728539.

  21. 21.

    Kahokehr AA, Gilling PJ. Which laser works best for benign prostatic hyperplasia? Curr Urol Rep. 2013; 14(6):614-9.

  22. 22.

    Kitzing YX, Prando A, Varol C, Karczmar GS, Maclean F, Oto A. Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation. RadioGraphics. 2016; 36(1):162-75.

  23. 23.

    Semple JE. Surgical capsule of the benign enlargement of the prostate. Its development and action. Br Med J. 1963; 1(5346):1640-3.

  24. 24.

    White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 1995; 195(2):385-90.

  25. 25.

    Chatterjee A, Tokdemir S, Gallan AJ, et al. Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate. AJR Am J Roentgenol. 2019; 212(1):124-9.

  26. 26.

    Sharif-Afshar AR, Feng T, Koopman S, et al. Impact of post prostate biopsy hemorrhage on multiparametric magnetic resonance imaging. Can J Urol. 2015; 22(2):7698-702.

  27. 27.

    Qayyum A, Coakley FV, Lu Y, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2004; 183(4):1079-83.

  28. 28.

    Rosenkrantz AB, Kopec M, Kong X, et al. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging. 2010; 31(6):1387-94.

  29. 29.

    Barrett T, Vargas HA, Akin O, Goldman DA, Hricak H. Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. Radiology. 2012; 263(3):751-7.

  30. 30.

    Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology. 1998; 51(4):578-84.

  31. 31.

    Coker TJ, Dierfeldt DM. Acute Bacterial Prostatitis: Diagnosis and Management. Am Fam Physician. 2016; 93(2):114-20.

  32. 32.

    Holt JD, Garrett WA, McCurry TK, Teichman JM. Common Questions About Chronic Prostatitis. Am Fam Physician. 2016; 93(4):290-6.

  33. 33.

    Gurses B, Tasdelen N, Yencilek F, et al. Diagnostic utility of DTI in prostate cancer. Eur J Radiol. 2011; 79(2):172-6.

  34. 34.

    Rais-Bahrami S, Nix JW, Turkbey B, et al. Clinical and multiparametric MRI signatures of granulomatous prostatitis. Abdom Radiol (NY). 2017.

  35. 35.

    Shukla P, Gulwani HV, Kaur S. Granulomatous prostatitis: clinical and histomorphologic survey of the disease in a tertiary care hospital. Prostate Int. 2017; 5(1):29-34.

  36. 36.

    Stillwell TJ, Engen DE, Farrow GM. The clinical spectrum of granulomatous prostatitis: a report of 200 cases. J Urol. 1987; 138(2):320-3.

  37. 37.

    Bour L, Schull A, Delongchamps NB, et al. Multiparametric MRI features of granulomatous prostatitis and tubercular prostate abscess. Diagn Interv Imaging. 2013; 94(1):84-90.

  38. 38.

    Benedetti I, Bettin A, Reyes N. Inflammation and focal atrophy in prostate needle biopsy cores and association to prostatic adenocarcinoma. Ann Diagn Pathol. 2016; 24:55-61.

  39. 39.

    Freitas DM, Andriole GL, Jr., Castro-Santamaria R, Freedland SJ, Moreira DM. Extent of Baseline Prostate Atrophy Is Associated With Lower Incidence of Low- and High-grade Prostate Cancer on Repeat Biopsy. Urology. 2017; 103:161-6.

  40. 40.

    Tomas D, Kruslin B, Rogatsch H, Schafer G, Belicza M, Mikuz G. Different types of atrophy in the prostate with and without adenocarcinoma. Eur Urol. 2007; 51(1):98-103; discussion -4.

  41. 41.

    Billis A, Meirelles LR, Magna LA, Baracat J, Prando A, Ferreira U. Extent of prostatic atrophy in needle biopsies and serum PSA levels: is there an association? Urology. 2007; 69(5):927-30.

  42. 42.

    Guneyli S, Ward E, Thomas S, et al. Magnetic resonance imaging of benign prostatic hyperplasia. Diagn Interv Radiol. 2016; 22(3):215-9.

  43. 43.

    Chatterjee A, Gallan AJ, He D, et al. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. Abdom Radiol. 2019; 44(6):2233-43.

  44. 44.

    Oto A, Kayhan A, Jiang Y, et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology. 2010; 257(3):715-23.

  45. 45.

    McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988; 12(12):897-906.

  46. 46.

    King CR, Ferrari M, Brooks JD. Prognostic significance of prostate cancer originating from the transition zone. Urol Oncol. 2009; 27(6):592-7.

  47. 47.

    Hoeks CM, Hambrock T, Yakar D, et al. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology. 2013; 266(1):207-17.

  48. 48.

    Oyen RH, Van de Voorde WM, Van Poppel HP, et al. Benign hyperplastic nodules that originate in the peripheral zone of the prostate gland. Radiology. 1993; 189(3):707-11.

  49. 49.

    Liu X, Tang J, Yang JC, Zhang Y, Shi HY. [An autopsy specimen study of benign hyperplastic nodules in the peripheral zone of the prostate]. Zhonghua Nan Ke Xue. 2008; 14(4):307-10.

  50. 50.

    Tang J, Yang JC, Zhang Y, et al. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study. BJU Int. 2007; 100(5):1091-6.

  51. 51.

    Muglia VF, Saber G, Maggioni G, Jr., Monteiro AJ. MRI findings of prostate stromal tumour of uncertain malignant potential: a case report. Br J Radiol. 2011; 84(1006):e194-6.

  52. 52.

    Klimas R, Bennett B, Gardner WA, Jr. Prostatic calculi: a review. Prostate. 1985; 7(1):91-6.

  53. 53.

    Sfanos KS, Wilson BA, De Marzo AM, Isaacs WB. Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proc Natl Acad Sci U S A. 2009; 106(9):3443-8.

  54. 54.

    Christian JD, Lamm TC, Morrow JF, Bostwick DG. Corpora amylacea in adenocarcinoma of the prostate: incidence and histology within needle core biopsies. Mod Pathol. 2005; 18(1):36-9.

  55. 55.

    Caglic I, Hansen NL, Slough RA, Patterson AJ, Barrett T. Evaluating the effect of rectal distension on prostate multiparametric MRI image quality. European Journal of Radiology. 2017; 90:174-80.

Download references

Author information

Correspondence to Aytekin Oto.

Ethics declarations

Conflict of interest

Dr. Aritrick Chatterjee and Dr. Stephen Thomas have no disclosures. Dr. Aytekin Oto has the following disclosures. Research Grant, Koninklijke Philips NV Research Grant, Guerbet SA Research Grant, Profound Medical Inc. Medical Advisory Board, Profound Medical Inc Speaker, Bracco Group.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chatterjee, A., Thomas, S. & Oto, A. Prostate MR: pitfalls and benign lesions. Abdom Radiol (2019). https://doi.org/10.1007/s00261-019-02302-x

Download citation

Keywords

  • mpMRI
  • Prostate cancer
  • DWI
  • Pitfalls
  • Benign lesions